Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Oxaliplatin + Capecitabine + Radiotherapy in Locally-Advanced Rectal Cancer
NCT00226941Phase 2Terminated
- Start
- Jun 2004
- Primary completion
- Mar 2008
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140, oxaliplatin in rectal cancer. Started Jun 2004; status: terminated.
02
Drugs
KL-140oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00226941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226941.